| 特应性皮炎的靶向治疗药物研究进展 |
| |
| 引用本文： | 刘方方,王华. 特应性皮炎的靶向治疗药物研究进展[J]. 儿科药学杂志, 2019, 25(11): 55-58 |
| |
| 作者姓名： | 刘方方 王华 |
| |
| 作者单位： | 重庆医科大学附属儿童医院,儿童发育疾病研究教育部重点实验室,儿童发育重大疾病国家国际科技合作基地,儿科学重庆市重点实验室,重庆400014 |
| |
| 摘 要： | 特应性皮炎(atopic dermatitis,AD)是一种与遗传、免疫功能异常有关的慢性、复发性、炎症性皮肤病,常在婴儿和儿童期即开始发病。
|
Progress of Targeted Treatment of Atopic Dermatitis |
| |
| Liu Fangfang,Wang Hua. Progress of Targeted Treatment of Atopic Dermatitis[J]. Journal of Pediatric Pharmacy, 2019, 25(11): 55-58 |
| |
| Authors: | Liu Fangfang Wang Hua |
| |
| Affiliation: | Children''s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders,Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《儿科药学杂志》浏览原始摘要信息 |
|
点击此处可从《儿科药学杂志》下载全文 |
|
